Invention Grant
US08524661B2 Inhibiting serum response factor (SRF) to improve glycemic control
有权
抑制血清反应因子（SRF）来改善血糖控制
- Patent Title: Inhibiting serum response factor (SRF) to improve glycemic control
- Patent Title (中): 抑制血清反应因子（SRF）来改善血糖控制
-
Application No.: US13180124Application Date: 2011-07-11
-
Publication No.: US08524661B2Publication Date: 2013-09-03
- Inventor: Mary Elizabeth Patti , Wanzhu Jin , Allison B. Goldine
- Applicant: Mary Elizabeth Patti , Wanzhu Jin , Allison B. Goldine
- Applicant Address: US MA Boston
- Assignee: Joslin Diabetes Center, Inc.
- Current Assignee: Joslin Diabetes Center, Inc.
- Current Assignee Address: US MA Boston
- Agency: Pierce Atwood LLP
- Agent Kevin M. Farrell, Esq.; David J. Wilson, Esq.
- Main IPC: A61K38/28
- IPC: A61K38/28 ; A61K5/50 ; A61K7/12
Abstract:
Described are methods of improving glycemic control/improving insulin sensitivity by administering an inhibitor of serum response factor (SRF) activity, and methods of identifying new compounds for use in the described methods of treatment.
Public/Granted literature
- US20120028895A1 Inhibiting Serum Response Factor (SRF) to Improve Glycemic Control Public/Granted day:2012-02-02
Information query
IPC分类:
